Skin Disease for Clinicians

About this session:

Victoria Werth, M.D., will discuss the identification and treatment of skin manifestations associated with dermatomyositis, including diagnostic criteria, various skin manifestations, and the latest treatment approaches and insights into the complexities of managing dermatomyositis, aiming to improve patient outcomes and quality of life.

About Dr. Werth:

Dr. Werth is a Professor of Dermatology and Medicine at the University of Pennsylvania School of Medicine and Chief of the Division of Dermatology at the Philadelphia Veterans Administration Hospital. Dr. Werth earned her medical degree from Johns Hopkins University School of Medicine in Baltimore, Maryland. Her professional achievements include being recognized for her groundbreaking research in autoimmune skin diseases, particularly in the areas of lupus and dermatomyositis. She has also published extensively in top-tier medical journals, presented her work at major scientific conferences, and received numerous awards and honors for her contributions to dermatology and autoimmune diseases.

The Potential of JAKs in Fighting JM

In our June 2024 “Ask the Doc” Town Hall, Dr. Julie Paik joins in a Q&A session to shed light on what JAK inhibitors are, how they work in JM, when parents might consider discussing JAKs as a treatment option, and the pros and cons of their use.

Doctor with parent and juvenile myositis patient.

Treatment Plans for Juvenile Myositis

A treatment plan is based on many factors, including the severity and expression of the juvenile dermatomyositis (JDM). Each case is different and the symptoms can change over time.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.